Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14 may promote neurodegeneration.
LATEST NEWS
- Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
- New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures